Test Bank for Lehne’s Pharmacotherapeutics for Advanced Practice Providers: Nurses and Physician Assistants 3rd Edition by Laura D. Rosenthal – Complete Exam Prep & Study Guide 2025–2026

TESTBANK
v

, Pharmacotherapeutics forAdvancedPracticeNursePrescribers,4th v v v v v v




edition Woo Robinson Test Bank v v v v v




Chapter1. The Role of the Nurse Practitioner as PrescriberMultiple Choice
v v v v v v v v v v




Identifythe choice that best completes thestatement or answers the question.
v v v v v v v v v v v




1. Nurse practitioner prescriptive authorityis regulated by:
v v v v v v v




1. The National Council of State Boards of Nursing
v v v v v v v




2. The U.S. Drug Enforcement Administration
v v v v




3. The State Board of Nursing for each state
v v v v v v v




4. The State Board of Pharmacy v v v v




2. Thebenefits to the patient of having an Advanced Practice Registered Nurse (APRN)prescriber
v v v v v v v v v v v v v v




include:
v




1. Nurses know more about Pharmacologythan other prescribers because theytakeit
v v v v v v v v v v v




both in their basic nursing program and in their APRN program.
v v v v v v v v v v v




2. Nurses care for the patient from a holistic approach and include the patient in
v v v v v v v v v v v v v




decision making regarding their care.
v v v v v




3. APRNs are less likelyto prescribe narcotics and other controlled substances.
v v v v v v v v v v




4. APRNs areable to prescribe independently in all states, whereas a physician’s
v v v v v v v v v v v




assistant needs to have a physician supervising their practice.
v v v v v v v v v




3. Clinical judgment in prescribing includes:
v v v v v




1. Factoring in the cost to the patient of the medication prescribed v v v v v v v v v v




2. Always prescribing the newest medication available for the disease process
v v v v v v v v v




3. Handing out drug samples to poor patients v v v v v v




4. Prescribingall generic medications to cut costs v v v v v v




4. Criteria for choosing an effective drug for a disorder include:
v v v v v v v v v v




1. Asking the patient what drug theythink would work best for them
v v v v v v v v v v v




2. Consultingnationallyrecognized guidelines for disease management v v v v v v




3. Prescribingmedications that are available as samples before writing a prescription v v v v v v v v v v




4. Following U.S. Drug Enforcement Administration guidelines for prescribing v v v v v v v




5. Nurse practitioner practice may thriveunder health-care reform because of:
v v v v v v v v v v




1. The demonstrated ability of nursepractitioners to control costs and improvepatient
v v v v v v v v v v v




outcomes v




2. Thefact that nurse practitioners will be able to practice independently
v v v v v v v v v v




3. The fact that nurse practitioners will have full reimbursement under health-
v v v v v v v v v v




care reform v v




4. The ability to shift accountability for Medicaid to the state level
v v v v v v v v v v

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th
v v v v v v




edition Woo Robinson Test Bank v v v v v




Chapter 1.The Role of the Nurse Practitioner as Prescriber
v v v v v v v v v




Answer Section
v v




MULTIPLE CHOICE v




1. ANS: v v 3 PTS: v 1
2. ANS: v v 2 PTS: v 1
3. ANS: v v 1 PTS: v 1
4. ANS: v v 2 PTS: v 1
5. ANS: v v 1 PTS: v 1

, Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 4th v v v v v v




edition Woo Robinson Test Bank v v v v v




Chapter2. Review of theBasic Principles of Pharmacology
v v v v v v v v




v Multiple Choice
v




Identify the choice that best completes the statement or answers the question.
v v v v v v v v v v v




1. A patient’s nutritional intake and laboratoryresults reflect hypoalbuminemia. This is critical to
v v v v v v v v v v v v v




prescribing because:
v v




1. Distribution of drugs to target tissue maybe affected. v v v v v v v v




2. The solubilityof the drug will not match the site of absorption.
v v v v v v v v v v v




3. There will be less free drug available to generate an effect.
v v v v v v v v v v




4. Drugs bound to albumin are readily excreted by the kidneys.
v v v v v v v v v




2. Drugs that have a significant first-pass effect:
v v v v v v v




1. Must be given by the enteral (oral) route only v v v v v v v v




2. Bypass the hepatic circulation v v v




3. Are rapidlymetabolized by the liver and may have little if any desired action
v v v v v v v v v v v v v




4. Are converted by the liver to more active and fat-soluble forms
v v v v v v v v v v




3. The route of excretion of a volatile drug will likely be the:
v v v v v v v v v v v v v




1. Kidneys
2. Lungs
3. Bileand feces v v




4. Skin

4. Medroxyprogesterone (Depo Provera) is prescribed intramuscularly(IM) to create astorage
v v v v v v v v v v v




reservoir of the drug. Storage reservoirs:
v v v v v v




1. Assurethat the drug will reach its intended target tissue v v v v v v v v v




2. Are the reason for giving loading doses
v v v v v v




3. Increase the length of time a drug is available and active v v v v v v v v v v




4. Are most common in collagen tissues
v v v v v




5. The NP chooses to give cephalexin every8 hours based on knowledge of the drug’s:
v v v v v v v v v v v v v v v




1. Propensityto go to the target receptor v v v v v v




2. Biological half-life v




3. Pharmacodynamics
4. Safety and side effects v v v




6. Azithromycin dosing requires that the first day’s dosage be twice those of the other 4 days of the
v v v v v v v v v v v v v v v v v v




prescription. This is considered a loading dose. A loading dose:
v v v v v v v v v v




1. Rapidlyachieves drug levels in the therapeutic range v v v v v v v




2. Requires four- to five-half-lives to attain v v v v v




3. Is influenced byrenal function
v v v v




4. Is directly related to the drug circulating to the target tissues
v v v v v v v v v v




7. The point in time on the drug concentration curve that indicates the first sign of a therapeutic effect is the:
v v v v v v v v v v v v v v v v v v v v




1. Minimum adverse effect level v v v




2. Peak of action v v